Šalis: Didžioji Britanija
kalba: anglų
Šaltinis: HMA (Heads of Medicines Agencies)
Amoxicillin as amoxicillin trihydrate 40 mg, clavulanic acid 40 ug
Norbrook Laboratories Limited
QJ01CR02
Tablet
amoxicillin and enzyme inhibitor
Dogs Non Food
2011-11-24
Revised: November 2011 AN: 01183/2011 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Noroclav 50 mg Tablets for Dogs and Cats (RMS UK) Noroclav 50 mg Tablets for Dogs and Cats (in CMS AT, BE, IS, IT, NL, NO, PT, ES, IE except SE, FR and DK) Noroclav Vet 40 mg/10 mg Tablets for Dogs and Cats (SE) Noroclav 50mg Tablets for Dogs and Cats (FR) Noroclav Vet 50mg Tablets for Dogs and Cats (DK) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per tablet: ACTIVE INGREDIENTS: Amoxicillin (as amoxicillin trihydrate) 40 mg Clavulanic acid (as Potassium clavulanate) 10 mg EXCIPIENTS: Carmoisine Lake (E122) 0. 245mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Tablet. Round pink biconvex tablet with a score line and 50 embossed on opposing faces. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs and cats. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of the following infections caused by lactamase producing strains of bacteria sensitive to amoxicillin in combination with clavulanic acid: Skin infections (including superficial and deep pyodermas) caused by susceptible Staphylococci. Urinary tract infections caused by susceptible Staphylococci or _Escherichia _ _coli_. Respiratory infections caused by susceptible Staphylococci. Revised: November 2011 AN: 01183/2011 Page 2 of 7 Enteritis caused by susceptible _Escherichia coli_. It is recommended to carry out suitable tests Perskaitykite visą dokumentą